Literature DB >> 19030907

Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice.

Timm Bauer1, Rainer Hoffmann, Claus Jünger, Oliver Koeth, Ralf Zahn, Anselm Gitt, Tobias Heer, Kurt Bestehorn, Jochen Senges, Uwe Zeymer.   

Abstract

BACKGROUND: Primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) improves outcome in comparison to fibrinolysis. However, it is unclear whether patients treated in interventional facilities with 24-h primary PCI service have lower rates of adverse events.
METHODS: We analyzed data of consecutive patients with STEMI prospectively enrolled in the German Acute Coronary Syndromes registry between July 2000 and November 2002 who were admitted to hospitals with catheterisation laboratory.
RESULTS: Overall 6,350 patients were divided into two groups: 2,779 (43.8%) were treated in hospitals with and 3,571 (56.2%) without 24-h on-call cardiac catheter laboratories. 83.0% of the patients at facilities with and only 69.9% of the patients at facilities without 24-h PCI service received early reperfusion therapy (P < 0.001). Hospital death (7.4% vs. 9.9%, P < 0.001), non-fatal myocardial reinfarction (2.5% vs. 6.4%, P < 0.0001) and stroke (0.3 vs. 1.0%, P < 0.01) occurred significantly less often in patients treated in hospitals with 24-h primary PCI service. After adjustment for the confounding factors in the propensity score analysis the 24-h on-call strategy remained superior for the combined endpoint of death, reinfarction and stroke (OR 0.63, 95% CI 0.54-0.75).
CONCLUSIONS: In clinical practice the rate of patients receiving reperfusion therapy was significantly higher in hospitals with 24-h primary PCI service which was associated with an improved in-hospital outcome. Though the data was collected at a time that does not completely represent current clinical practice, these results could have an impact on planning efficient infarct networks in the future.

Entities:  

Mesh:

Year:  2008        PMID: 19030907     DOI: 10.1007/s00392-008-0738-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  25 in total

1.  Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database.

Authors:  Mauro Moscucci; David Share; Dean Smith; Michael J O'Donnell; Arthur Riba; Richard McNamara; Thomas Lalonde; Anthony C Defranco; Kirit Patel; Eva Kline Rogers; Chris D'Haem; Milind Karve; Kim A Eagle
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

2.  Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction?

Authors:  J M Juliard; D Himbert; J L Golmard; P Aubry; G J Karrillon; A Boccara; H Benamer; P G Steg
Journal:  J Am Coll Cardiol       Date:  1997-07       Impact factor: 24.094

3.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.

Authors:  J G Canto; N R Every; D J Magid; W J Rogers; J A Malmgren; P D Frederick; W J French; A J Tiefenbrunn; V K Misra; C I Kiefe; H V Barron
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

4.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

5.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

6.  Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.

Authors:  R Zahn; S Schuster; R Schiele; K Seidl; T Voigtländer; J Meyer; K E Hauptmann; M Gottwik; G Berg; T Kunz; U Gieseler; M Jakob; J Senges
Journal:  Catheter Cardiovasc Interv       Date:  1999-02       Impact factor: 2.692

7.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

8.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).

Authors:  Elliott M. Antman; Daniel T. Anbe; Paul Wayne Armstrong; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Hochman; Harlan M. Krumholz; Frederick G. Kushner; Gervasio A. Lamas; Charles J. Mullany; Joseph P. Ornato; David L. Pearle; Michael A. Sloan; Sidney C. Smith; Joseph S. Alpert; Jeffrey L. Anderson; David P. Faxon; Valentin Fuster; Raymond J. Gibbons; Gabriel Gregoratos; Jonathan L. Halperin; Loren F. Hiratzka; Sharon Ann Hunt; Alice K. Jacobs; Joseph P. Ornato
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

9.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

Review 10.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

View more
  16 in total

1.  Influence of algorithm-based analgesia and sedation in patients after sudden cardiac arrest.

Authors:  Nadine Abanador-Kamper; Lars Kamper; Judith Wolfertz; Wilfried Dinh; Petra Thürmann; Melchior Seyfarth
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

2.  Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre.

Authors:  Ulrike M Müller; Ingo Eitel; Kristina Eckrich; Sandra Erbs; Axel Linke; Sven Möbius-Winkler; Meinhard Mende; Gerhard C Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2010-10-24       Impact factor: 5.460

3.  Beneficial effect of delayed reperfusion in ST elevation myocardial infarction despite transmural necrosis documented in cardiac magnetic resonance imaging.

Authors:  Günter Pilz; Tobias Heer; Elisabeth Harrer; Markus Klos; Berthold Höfling
Journal:  Clin Res Cardiol       Date:  2010-02-10       Impact factor: 5.460

4.  Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials.

Authors:  Alban Dibra; Klaus Tiroch; Stefanie Schulz; Henning Kelbaek; Christian Spaulding; Gerrit J Laarman; Marco Valgimigli; Emilio Di Lorenzo; Christoph Kaiser; Ilkka Tierala; Julinda Mehilli; Gianluca Campo; Leif Thuesen; Maarten A Vink; Martin J Schalij; Roberto Violini; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2010-03-11       Impact factor: 5.460

5.  Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany.

Authors:  U Zeymer; H Heuer; P Schwimmbeck; S Genth-Zotz; K Wolff; C A Nienaber
Journal:  Herz       Date:  2014-11-07       Impact factor: 1.443

6.  Direct admission versus transfer of AMI patients for primary PCI.

Authors:  Christoph Liebetrau; Sebastian Szardien; Johannes Rixe; Mariella Woelken; Andreas Rolf; Timm Bauer; Holger Nef; Helge Möllmann; Christian Hamm; Michael Weber
Journal:  Clin Res Cardiol       Date:  2010-09-21       Impact factor: 5.460

7.  Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network.

Authors:  Ralf Birkemeyer; Andreas Rillig; Annette Koch; Tomislav Miljak; Markus Kunze; Udo Meyerfeldt; Wolfgang Steffen; Martin Soballa; Carsten Ranke; Roland Prassler; Albert Benzing; Werner Jung
Journal:  Clin Res Cardiol       Date:  2010-07-06       Impact factor: 5.460

8.  Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy.

Authors:  Gjin Ndrepepa; Dritan Keta; Stefanie Schulz; Robert A Byrne; Julinda Mehilli; Jürgen Pache; Melchior Seyfarth; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2009-09-10       Impact factor: 5.460

9.  Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock.

Authors:  Oliver Koeth; Ralf Zahn; Tobias Heer; Timm Bauer; Claus Juenger; Bärbel Klein; Anselm Kai Gitt; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2009-10-25       Impact factor: 5.460

10.  Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.

Authors:  Ingo Wickenbrock; Christian Perings; Petra Maagh; Ivo Quack; Marc van Bracht; Magnus W Prull; Gunnar Plehn; Hans-Joachim Trappe; Axel Meissner
Journal:  Clin Res Cardiol       Date:  2009-10-23       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.